The novel Akt inhibitor Palomid 529 (P529) enhances the effect of radiotherapy in prostate cancerRoque Díaz(Universidad de Navarra), Alfonso Calvo(Instituto de Salud Carlos III)British Journal of CancerFebruary 24, 200910.1038/sj.bjc.6604938Cited by 53SaveCiteExport RISWatch citationsRelated PapersThe C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma|Oncogene|2000|265Antitumor and antiangiogenic effect of the dual EGFR and HER-2 tyrosine kinase inhibitor lapatinib in a lung cancer model|BMC Cancer|2010|86Cancer Epigenetic Biomarkers in Liquid Biopsy for High Incidence Malignancies|Cancers|2021|76